Abstract
INTRODUCTION
Thrombus formation usually occurs in the left atrial appendage (LAA) in patients with atrial fibrillation (AF), and the effectiveness of LAA closure for prophylaxis of cardiogenic stroke has been confirmed [1, 2] . Various methods of LAA closure have been suggested [3] [4] [5] [6] , and thoracoscopic left atrial appendectomy is an established, effective method [6] . Compared with other LAA closure methods, resection is the most secure, as recanalization to the LAA can never happen. However, the adverse effects of LAA resection have not yet been evaluated, because isolated LAA resection is not usually performed.
LAA closure (resection or ligation) combined with other cardiac operations is performed generally, but the independent influence of LAA closure cannot be evaluated, because other surgical factors such as cardiopulmonary bypass, valve surgery or coronary artery bypass grafting have a significant influence on the outcome.
In this study, we explored the safety and invasiveness of LAA resection by analysing our thoracoscopic stand-alone left atrial appendectomy experience.
METHODS

Patients
Eighty-seven patients with chronic or paroxysmal AF who had a history of cardiogenic stroke/thromboembolism or had a high †Presented at the 31st Annual Meeting of the European Association for CardioThoracic Surgery, Vienna, Austria, 7-10 October 2017.
risk of thromboembolism and/or adverse effects of bleeding under anticoagulation therapy were selected for thoracoscopic left atrial appendectomy from July 2014 to July 2017 (endovascular devices and clip devices for the LAA closure are not currently approved in Japan).
The inclusion criteria were as follows: (i) a history of cardiogenic stroke or thromboembolism, (ii) a history of bleeding due to anticoagulation therapy, (iii) a (potentially) high risk of thromboembolism and/or bleeding [congestive heart failure, hypertension, age > _ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack to thromboembolism, vascular disease, age 65-74 years and sex category (CHA 2 DS 2 -VASc) and/or hypertension, abnormal renal and liver function, stroke, bleeding, labile INR, elderly, drugs or alcohol (HAS-BLED) scores >2 points) and (iv) an LAA with a high risk of thrombus formation [as determined by echocardiography or cardiac computed tomography (CT)]. In our strategy, catheter ablation was performed after LAA resection in 2 stages if necessary; thus, no patient underwent ablation in this study.
To ensure that no clot existed in the LAA, preoperative cardiac CT with contrast medium was performed for all patients, except those who were contraindicated due to renal dysfunction, who instead underwent preoperative transoesophageal echocardiography. If a thrombus was detected, the operation was postponed.
Postoperative regular check-ups were performed at an outpatient clinic. Cardiac CT and echocardiography were performed twice-on the 2nd postoperative day and 3 months after the operation-to evaluate the stump of the LAA resection. Ten patients did not undergo cardiac CT because of chronic renal dysfunction (n = 9) and allergy to the contrast medium (n = 1). After confirming the absence of thrombus and the smooth stump of the LAA after resection, anticoagulants were withdrawn, unless the patients had a very high risk of thromboembolism or low risk of bleeding because of anticoagulant use.
Surgical procedure
The procedure was performed as follows in the original fashion [6] : each patient was prepped and draped in the right lateral recumbent position with differential lung ventilation. Four thoracoscopic ports (at the 4th intercostal space on the clavicle middle line for the thoracoscope, at the 7th intercostal space on the middle axillary line for the thoracoscopic cutter, at the 3rd intercostal space on the clavicle middle line and at the fourth intercostal space on the anterior axillary line for the forceps) were usually made in the left thorax. The LAA was exposed through pericardiotomy while preserving the left phrenic nerve, and we divided the baseline of the LAA with a thoracoscopic cutter (Fig. 1, Videos 1 and 2 ). The thoracoscopic cutter we used was an automatic triple stapling type (Powered ECHELON; Ethicon ENDO-Surgery, Cincinnati, OH, USA). A single chest tube was left in the base of the left pleural cavity via the port. All patients were extubated in the operating room. Although we routinely prepared for emergent thoracotomy and cardiopulmonary bypass due to the possible occurrence of severe bleeding, there were no cases of severe bleeding.
All patients gave their informed consent for the operation. The protocol and indications were approved by the institutional ethics committee for each case.
Statistical analyses
Continuous data are presented as the mean ± standard deviation. Categorical variables are presented as the count and percentage. The preoperative and postoperative data were compared using the Wilcoxon's signed-rank sum test. Statistical analyses were performed with the Prism 7 software program (Version 7.0a; GraphPad Software Inc., San Diego, CA, USA). The left atrial appendage (LAA) was completely resected with a thoracoscopic linear cutter.
Video 2:
The baseline of the left atrial appendage was divided with a thoracoscopic cutter.
Video 1:
The left atrial appendage was exposed through pericardiotomy while preserving the left phrenic nerve.
RESULTS
Baseline characteristics
Sixty-eight male and 19 female patients (mean age 68 ± 9 years) experienced AF for 4.2 (0.7-6.6) years, and the LA diameter was dilated to 43 ± 5 mm on average (Table 1) . Twenty-nine (33%) patients had a history of cardiogenic thromboembolism. Eightyfour patients had been prescribed preoperative anticoagulant medication. The mean CHA 2 DS 2 -VASc score was 2.9 ± 1.6 (range 1-7).
Surgery information
The mean volume of bleeding in the operation was very small (<10 ml). Because of pleural adhesion in 1 case, we converted the procedure to minithoracotomy in the left thorax. The average operation time was 41 ± 14 min. The mean length of the postoperative hospital stay was 3.8 ± 1.8 days. (With regard to pain and general condition, patients could leave hospital on the day after surgery. Because there is no incentive for early discharge in the Japanese insurance system, the patients preferred to be discharged after undergoing CT on the 2nd postoperative day.) All patients were discharged while maintaining their preoperative activities of daily living without major complications.
Perioperative changes
The preoperative and postoperative data are as follows: left atrial diameter 43 ± 5 mm and 43 ± 5 mm (P = 0.8); left ventricular diameter of systole/diastole 50 ± 5/35 ± 6 mm and 48 ± 5/34 ± 6 mm (P < 0.01); ejection fraction 57 ± 10% and 56 ± 10% (P = 0.11); brain natriuretic peptide (BNP) 97 ± 77 pg/ml and 72 ± 65 pg/ml (P < 0.01) and human atrial natriuretic peptide (hANP) 73 ± 64 pg/ ml and 96 ± 67 pg/ml (P = 0.03), respectively (Figs 2 and 3) . The postoperative measurements of BNP and hANP were routinely performed on postoperative day 1 (morning). The BNP and hANP values of the 9 patients with renal dysfunction (estimated glomerular filtration rate <45 ml/min/1.73 m 3 ) were excluded because renal dysfunction was associated with a drastic change in BNP. The left atrial diameter and ejection fraction were not significantly different after surgery than before. In all cases, a smooth stump of the resected LAA was confirmed (Fig. 4) . No postoperative stroke or bleeding events occurred. (A) There were no marked differences in the BNP levels between baseline and 1 day after resection (97 ± 77 pg/ml to 72 ± 65 pg/ml) (P < 0.01). (B) Left atrial appendage resection resulted in a significant increase in the hANP levels (73 ± 64 pg/ml to 96 ± 67 pg/ml; P = 0.03). The BNP and hANP values of the 9 patients with renal dysfunction (estimated glomerular filtration rate <45 ml/min/1.73 m 3 ) were excluded. BNP: brain natriuretic peptide; hANP: human atrial natriuretic peptide.
DISCUSSION
This study reported the isolated influence of LAA resection. The concept of LAA occlusion for the prophylaxis of cardiogenic thromboembolism has developed [2] [3] [4] [5] [6] . LAA occlusion occurs via a number of mechanisms, and resection is the most secure method of resolution with respect to preventing thrombus formation. However, evaluating the independent risk of LAA resection is difficult, because other cardiac operations are usually accompanied by LAA resection, and the effect of those operations on the outcomes of LAA resection cannot be excluded. This study detected almost no adverse effects of LAA resection. The left ventricular contraction and cardiac endocrine secretion were not significantly affected by LAA resection, and no major complications associated with LAA resection were found.
Safety
In any operation, the cutting method always carries a risk of bleeding. To reduce the risk of bleeding, ligation and sutures are often chosen for LAA occlusion [7] , and resection is not preferred. With the development of the autostapling linear cutter, the risk of bleeding has been greatly reduced, and a linear cutter is usually used for cutting tissues during surgery. Its application for LAA resection was therefore natural, and as a result, slight bleeding was detected. We prefer the Powered Echelon device, but any type of tristapler linear cutter with the same thickness can be used. A double stapler is unfavourable for cutting the LAA, because blood oozing from the stump was observed in some cases just after cutting.
Effects on the cardiac function
The LAA was reported to function as the left atrial reservoir [8] , so we were concerned that the cardiac function might be negatively influenced by LAA resection. However, we found that LAA resection had no effect on the ventricular contraction. De Maat et al. [9] reported that surgical LAA exclusion did not impair left atrial contraction. Although the study population was limited (16 patients) and not a stand-alone LAA amputation (including pulmonary vein isolation), the results supported our results. In contrast, Tabata et al. [8] reported that the LAA played an important role in the LA function, but all of their patients had sinus rhythm in that study. Kamohara et al. [10] showed the impact of LAA exclusion on the left atrial function in their experiment. In that report, the mongrel dog models used also had sinus rhythm. Thus, the role of the LAA in patients with AF remains unclear, and we inferred that its important role was reduced in hearts with AF.
With regard to endocrine secretion, some studies have reported an association between AF and the BNP level [11] [12] [13] . Cruz-Gonzalez et al. [11] reported that the BNP level did not differ markedly between baseline and 24 h after LAA occlusion device implantation. Majunke et al. [12] showed that LAA closure resulted in a significant increase in the ANP and BNP levels after the procedure. This trend in the ANP is the same as in this study, AF: atrial fibrillation; CAD: coronary artery disease; CHA 2 DS 2 -VASc: congestive heart failure, hypertension, age > _ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack to thromboembolism, vascular disease, age 65-74 years and sex category; DL: dyslipidaemia; DM: diabetes mellitus; EF: ejection fraction; HT: hypertension; LAD: left atrial diameter; LVDd/Ds: left ventricular diameter of diastole and systole; NYHA: New York Heart Association; PAD: periarterial disease; SD: standard deviation.
but the findings for the BNP are different from those in our study. As for BNP and hANP, surgical invasion, general anaesthesia and changes in the body fluid volume in the perioperative period influence these values; thus, it appears that various perioperative changes that depended on the case occurred in our study. Although the method used for LAA exclusion in our study (resection) is not device occlusion, LAA resection might still exert some effect on endocrine secretion. The clinical impact of these results remains unclear and must be evaluated in future studies.
Comparison with other closure methods
Other ways of performing LAA occlusion exist, and each way has its own merits and risks [14] . First, direct suture is often performed in mitral valve surgery. Usually, two types of suturing are performed: purse-string suture and over-and-over suture. Pursestring suture has the advantage of being easy and quick to perform but is associated with a high risk of recanalization. Overand-over suture may be associated with a lower risk of recanalization; however, the rate of incomplete closure is reported to be over 30% with this modality [15] . Second, ligation is sometimes performed in cardiac surgery (excluding mitral valve surgery). The advantages and risks of ligation regarding the closure are similar to those of purse-string suture, but ligation is also associated with a risk of bleeding. Kawamura et al. [16] reported that LAA ligation might lead to a decrease in atrial dispersion. Pillarisetti et al. [17] also reported centric leakage in association with the use of an epicardial ligation device, and this phenomenon is called the 'gunnysack effect'.
Third, epicardial clipping has been recently developed. The AtriClip device (AtriCure, Mason, OH, USA), which can safely achieve almost complete LAA exclusion is now in practical use [18] . As this device is useful for both conventional and minimally invasive approaches and easy to manipulate, it might become the preferred method for performing LAA occlusion [19] . Some problems with the device exist and should be evaluated in future studies. The residual tissue of the ischaemic LAA remains noticeably after clipping, and the effect of this is unclear. Although the AtriClip comes in various sizes, there is greater variation in the size and shape of LAAs. In patients with a huge LAA, it is difficult to apply this device.
Although the methods, by which intravenous LAA occlusion devices, such as the WATCHMAN device (Boston Scientific, Marlborough, MA, USA) are applied, are quite different from the above-mentioned methods, they have recently been gaining popularity [4, 20, 21] . Endovascular devices have the merit of less invasiveness with implantation; however, the effect of prophylaxis for cardiogenic thromboembolism is almost equal to that of warfarin and insertion is still associated with the risk of complications [20, 21] . The long-term effect of the residual device after it is employed in the atrium is also unclear. As these issues can only be resolved in the future, endovascular LAA closure devices are currently being developed.
In comparison with these above-mentioned methods, LAA resection has the following merits: recanalization cannot occur after resection because the resected LAA can never develop again. Thus, the preventive effect from thrombus formation is permanent, and a sustained cardiogenic stroke prevention effect can be expected. In addition, no residual ischaemic tissue remains in the body (unlike when endovascular devices are used). When transoesophageal echocardiography reveals that the resection line is not appropriate, additional ligation can be performed to make the stump smooth. This technique contributes to eliminating blind-end space in the left atrium. Thus, it may be appropriate to call the procedure left atrial 'plasty' rather than 'resection'.
The long-term preventive effect of LAA resection against cardiogenic thromboembolism remains unclear, as the duration of follow-up is insufficient. We plan to continue further research once sufficient data are available.
Limitations
Several limitations associated with this study warrant mention. First, this study is not a randomized controlled study and was conducted in a single institution. Second, the patients selected for thoracoscopic left atrial appendectomy have sufficient cardiac function, and so the effects of LAA resection in patients with a low cardiac function remain unclear.
CONCLUSIONS
LAA resection does not negatively affect the heart function, and the risk of bleeding does not increase. LAA resection should therefore be aggressively considered in applicable cases.
